GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BioVaxys Technology Corp (OTCPK:BVAXF) » Definitions » Sale Of Investment

BioVaxys Technology (BioVaxys Technology) Sale Of Investment : $0.00 Mil (TTM As of Jul. 2023)


View and export this data going back to 2018. Start your Free Trial

What is BioVaxys Technology Sale Of Investment?

BioVaxys Technology's sale of investment for the three months ended in Jul. 2023 was $0.00 Mil. It means BioVaxys Technology gained $0.00 Mil from selling investments. BioVaxys Technology's sale of investment for the trailing twelve months (TTM) ended in Jul. 2023 was $0.00 Mil.

Compared with last quarter ($0.00 Mil in Apr. 2023 ), BioVaxys Technology gained the same money from selling investments in Jul. 2023 ($0.00 Mil).


BioVaxys Technology Sale Of Investment Historical Data

The historical data trend for BioVaxys Technology's Sale Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioVaxys Technology Sale Of Investment Chart

BioVaxys Technology Annual Data
Trend Oct18 Oct19 Oct20 Oct21 Oct22
Sale Of Investment
- - - - -

BioVaxys Technology Quarterly Data
Oct18 Jan19 Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23
Sale Of Investment Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

BioVaxys Technology Sale Of Investment Calculation

Sale of Investments represents cash inflow on the sale of investments in securities.

Sale Of Investment for the trailing twelve months (TTM) ended in Jul. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


BioVaxys Technology Sale Of Investment Related Terms

Thank you for viewing the detailed overview of BioVaxys Technology's Sale Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.


BioVaxys Technology (BioVaxys Technology) Business Description

Traded in Other Exchanges
Address
146 Thirtieth Street, Suite 100, Etobicoke, ON, CAN, M8W 3D4
BioVaxys Technology Corp is a clinical-stage biopharma company. The company develops antiviral and anticancer vaccine platforms to treat SARS-CoV-2 and other viral infections, as well as ovarian cancer and other solid tumor types.

BioVaxys Technology (BioVaxys Technology) Headlines